Beta Ventures
Fund Manager: Sarah Lee
Contact: +44 20 7946 0958, Sarah.Lee@betaventures.com
Address: 1 Canada Square, Canary Wharf, London, E14 5AB, United Kingdom

Fund Overview:

Fund Name: Beta Growth Fund
Focus: Healthcare
AUM: $3.2 billion
Investment Strategy: Growth equity
Key Investment Themes: Biotechnology, Pharmaceuticals
Recent Activities:

New Investments in Q2 2024: BioHealth Inc. ($10 million), PharmaTech Ltd. ($8 million)
NAV (as of June 30, 2024): $45.78 million
Performance in Q2 2024: Up by 5.5%
Market Dynamics:

Market Dynamics: Expansion
Noteworthy Headlines: Beta Ventures leads $10 million funding round in BioHealth Inc.
Investor Relations:

Investor Outreach: Hosting investor conference in Q4 2024 in London
Risk Factors:

Risk Factors: Regulatory changes in the healthcare sector
Track Record:

Track Record: Consistent performance with an average annual return of 8% over the past five years
Fees and Expenses:

Management fees: 2% of committed capital per annum during the Investment Period, reducing to 1.5% thereafter
GP Carried Interest: 20% of net profits
Fund Performance:

Fund Performance: NAV increased by $4.78 million or +11% of called capital in Q2 and stands at $50.56 million as of June 30, 2024
Risk Profile:

Risk Profile: Moderate to high due to the nature of healthcare investments
Management Team:

Management Team: Professionals with extensive experience in healthcare and finance
Investment Horizon:

Investment Horizon: 5-year primary term from final closing, with up to two (2) one-year extensions at GP’s discretion
Fund Size:

Fund Size: $45.78 million as of June 30, 2024
Liquidity:

Liquidity: Semi-annual liquidity windows for investors to redeem their shares
Fund Structure:

Fund Structure: Closed-ended fund with a 5-year primary term from final closing, with up to two (2) one-year extensions at GP’s discretion
Benchmark Comparison:

Benchmark Comparison: MSCI World Healthcare Index
Diversification:

Diversification: Portfolio diversified across various healthcare sectors including biotechnology and pharmaceuticals
Tax Considerations:

Tax Considerations: Investors should consult their tax advisors regarding potential tax implications of investing in the fund
Regulatory Compliance:

Regulatory Compliance: Complies with healthcare sector regulations and standards
ESG Factors:

ESG Factors: Integrates environmental, social, and governance considerations into investment decisions